Navigation Links
Reducing a severe side effect of a common anticancer drug

Cisplatin is one of the most widely used anticancer chemotherapeutics. However, it has some severe side effects in normal tissues, in particular it is toxic to the kidneys. Understanding the mechanisms underlying this toxicity could identify targets for drugs that could be given together with cisplatin to protect the kidney during chemotherapy. In this context, a team of researchers, led by Zheng Dong, at Georgia Health Sciences University, Augusta, has now identified the signaling protein PKC-delta as a critical regulator of cisplatin-mediated kidney toxicity in mice. Importantly, inhibiting PKC-delta not only protected the kidneys from the toxic effects of cisplatin but also enhanced the antitumor effects of the drug in several xenograft and syngeneic mouse tumor models. The team therefore suggests that targeting PKC-delta could help reduce the severe kidney toxicity that occurs in cancer patients undergoing chemotherapy with cisplatin and other cisplatin-based chemotherapeutics.


Contact: Karen Honey
Journal of Clinical Investigation

Page: 1

Related medicine news :

1. IOM report on reducing hypertension releases Feb. 22
2. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
3. UCSF study finds clinic-based HIV prevention is effective in reducing risk behaviors
4. Reducing Energy Consumption Dramatically: Green IT Conference Addresses Administration's Goals
5. The StoneEagle Group Upgrades Claims Authorization and Payment Process for SEcureCard and Vpay™ Solutions, Significantly Reducing Payment Time
6. Behavior therapy effective in reducing tics in children with Tourette syndrome, study finds
7. Reducing niacin intake can prevent obesity
8. Hip exercises found effective at reducing, eliminating common knee pain in runners
9. Help is on the phone: Reducing pain and depression of cancer
10. Gene may hold key to reducing spread of oral cancers
11. Romantic partner may play role in reducing vulvovaginal pain
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: